Cat. No. | Product name | CAS No. |
DCC4933 |
Stat3-in-13r
Novel inhibitor of STAT3, targeting SH2 domain |
|
DCC4934 |
Stat3-in-3
Novel potent and selective inhibitor of STAT3 |
2361304-26-7 |
DCC4935 |
Stat3-in-a69
Novel inhibitor targeting the DNA-binding domain of STAT3, suppressing tumor growth, metastasis and STAT3 target gene expression in vivo |
1164546-70-6 |
DCC4936 |
Stat3-in-b9
Novel inhibitor of signal transducer and activator of transcription 3 (STAT3), inhibiting the proliferation of tumor cells harboring abnormal activation of STAT3, such as, MDA-MB-468, MDA-MB-231 and DU145 |
825611-06-1 |
DCC4937 |
Stat5a-in-27
Novel cell-permeable selective STAT5a inhibitor prodrug, inhibiting tyrosine phosphorylation of STAT5a with selectivity over STAT5b in cultured human leukemia cells, and representing a valuable tool to define the non-redundant molecular functions of the t |
|
DCC4938 |
Stat5b-in-6a
Highly Potent and Selective Inhibitor of the Transcription Factor STAT5b |
|
DCC4939 |
Stemazole
Novel human stem/progenitor cells proliferation activator, promoting survival and preserving stemness in human embryonic stem cells |
317337-07-8 |
DCC4940 |
Sterigmatocystin
Natural inducer of G1 arrest in primary human esophageal epithelial cells but G2 arrest in immortalized cells |
10048-13-2 |
DCC4941 |
Stf-038533
Novel inhibitor of expression from canonical CREB response element-containing promoters |
423744-59-6 |
DCC4942 |
Stg -001
Novel RBP4 antagonist for treatment of Stargardt disease |
|
DCC4943 |
Stictic Acid
Natural anti-feline infectious peritonitis virus (FIPV) agent, specifically targeting the 3CLpro of FIPV and inhibiting its replication |
549-06-4 |
DCC4944 |
Sting Agonist 11
Novel non-nucleotide STING agonist, demonstrating antitumor activity when dosed intratumorally in a syngeneic mouse model |
|
DCC4945 |
Sting Inhibitor C-171
Novel covalent antagonist of hsSTING |
|
DCC4946 |
Stk-15
Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor |
844651-66-7 |
DCC4947 |
Stk-22
Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor |
843629-43-6 |
DCC4948 |
Stk295900
Dual inhibitor of topoisomerase 1 and 2, inducing G(2) arrest in the absence of DNA damage. Inhibitor of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay |
4402-17-9 |
DCC4949 |
Stk508411
Novel inhibitor of the heterogeneous ribonuclear protein A18 (hnRNP A18) |
664968-32-5 |
DCC4950 |
Stk630921
Novel blocker of IL-17A binding to the IL-17A receptor (IL-17RA) |
1033850-63-3 |
DCC4951 |
Stk683963
Novel activator of cellular ATG4B activity |
370073-65-7 |
DCC4952 |
Stock1n-65837
Potent natural modulator of human Toll-like receptor 7 (TLR7) |
|
DCC4953 |
Streptolidine
Metablite of the Streptomyces antibiotics streptothricin and streptolin |
29307-61-7 |
DCC4954 |
Streptozocin
Antibiotic, being used as an antineoplastic agent and to induce diabetes in experimental animals |
18883-66-4 |